Ai Lin Leong

Title: The Innovations of Ai Lin Leong

Introduction

Ai Lin Leong is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. He holds a total of 3 patents that focus on significant advancements in the understanding and treatment of hepatitis B virus (HBV). His work has implications for both research and therapeutic applications.

Latest Patents

Leong's latest patents include an in vitro activity assay for human hepatitis B virus (HBV) DNA polymerase. This invention provides a method for screening inhibitors of HBV DNA polymerase, which is crucial for developing potential anti-HBV drugs. The assay utilizes a specific oligonucleotide in PCR amplification, allowing for the measurement of HBV DNA polymerase activity in various serum samples.

Another significant patent is related to a vaccine-induced hepatitis B viral strain. This invention describes an isolated strain of Hepatitis B virus, designated as Human Hepatitis B Virus Surface Antigen-'Ś-145 Singapore Strain. It includes details about the viral genome and various methods for utilizing the isolated nucleic acids and polypeptides associated with this strain.

Career Highlights

Ai Lin Leong has worked with the Government of the Republic of Singapore, contributing his expertise to various research initiatives. His work has been instrumental in advancing the understanding of hepatitis B and developing potential treatments.

Collaborations

Leong has collaborated with notable colleagues, including Chong Jin Oon and Gek Keow Lim, who have contributed to his research endeavors.

Conclusion

Ai Lin Leong's innovative work in the field of biotechnology, particularly concerning hepatitis B, showcases his commitment to advancing medical science. His patents reflect significant contributions that may lead to improved treatments for viral infections.